The Science

Your autonomic nervous system controls everything your body does without your conscious direction: heart rate, blood pressure, digestion, temperature regulation, breathing, sweating. It runs continuously in the background, adjusting constantly to keep your internal environment stable. In autonomic dysregulation, this system loses its ability to respond appropriately. It overreacts where it should be quiet. It underreacts where it should activate. It responds at the wrong time, in the wrong direction, or with the wrong intensity.

The most recognized form in this cluster is POTS (Postural Orthostatic Tachycardia Syndrome). In POTS, the simple act of standing up becomes a physiological challenge the body cannot smoothly manage. Instead of the normal modest heart rate increase that accompanies standing, the heart races dramatically, compensating for a failure to adequately redirect blood upward against gravity. The result is dizziness, palpitations, brain fog, nausea, and in severe cases, syncope. What feels like a cardiovascular problem is fundamentally a nervous system coordination failure.

Dysautonomia, the broader category, encompasses POTS and related conditions including orthostatic hypotension, neurocardiogenic syncope, and inappropriate sinus tachycardia. These share the underlying theme: the autonomic nervous system is not regulating as it should.

Mast cells are immune cells positioned at every interface between your body and the outside world: in your skin, gut lining, airways, mucosal surfaces, connective tissue, and near nerve endings. They act as sentinels, releasing chemical mediators (histamine, tryptase, prostaglandins, leukotrienes, and many others) in response to threats. In a healthy system, this release is calibrated, targeted, and self-limiting. In Mast Cell Activation Syndrome (MCAS), the release happens too easily, too broadly, and too persistently, without adequate provocation, or in response to triggers as mild as food, fragrance, temperature, or stress.

What makes MCAS particularly elusive is that it operates through a different immune pathway than conventional allergies. Standard allergy tests measure IgE-mediated responses. MCAS involves multiple additional pathways those tests don't capture.2 A person can test negative for every known allergen and still be experiencing genuine, severe mast cell-driven reactions throughout their body simultaneously.

Because mast cells reside in virtually every organ system, MCAS can present as almost any combination of symptoms in almost any location, which is why patients are frequently seen by multiple specialists without anyone connecting the picture. The pattern, across systems and over time, is the diagnosis.

Connective tissue is the body's structural framework: collagen and related proteins that give form, elasticity, and integrity to joints, skin, blood vessel walls, gut lining, ligaments, tendons, and organs. When connective tissue is dysregulated, this scaffolding becomes lax or fragile throughout the body simultaneously. The effects are not limited to joints that bend too far. The same structural compromise affects blood vessels (contributing to orthostatic intolerance), gut walls (contributing to dysmotility and reflux), mucosal surfaces (contributing to fragility and inflammation), and the microenvironment where mast cells live.

Hypermobility Spectrum Disorder (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) exist on a continuous spectrum, from generalized joint hypermobility with functional impairment through to hEDS with additional skin, autonomic, and systemic involvement. Neither condition has a confirmed genetic marker despite being heritable, which has historically made diagnosis difficult and contributed to decades of dismissal for many patients.

The Beighton score is the primary screening tool, but clinicians increasingly recognize that hypermobility's most disabling effects are often systemic rather than articular, and that a score alone captures only part of the picture.

Pain is a signal, not a measurement. Your nervous system normally amplifies pain when tissue is genuinely threatened, a useful alarm. In central sensitization, this amplification becomes chronic and self-sustaining, persisting long after any original injury or trigger has resolved. The nervous system turns up its own volume and cannot turn it back down. Inputs that shouldn't cause pain become painful. Pain that should be mild becomes severe. Sensory experiences that shouldn't be overwhelming, including light, sound, smell, touch, and vibration, become intolerable.

Migraine is the most recognized form of neurological sensitization in this cluster, and one of the most common comorbidities across POTS, MCAS, and HSD. The same mechanism also underlies widespread pain amplification, fibromyalgia-like presentations, the profound sensory hypersensitivities many patients experience, and much of what presents clinically as brain fog, a nervous system so sensitized that processing becomes inefficient.

Central sensitization is not psychological. It is a demonstrable neurophysiological state with measurable changes in spinal and cortical excitability, altered neurotransmitter balance, and neuroinflammatory markers.1 The persistent false narrative that these symptoms are anxiety or somatization has delayed appropriate treatment for many in this community by years or decades.